Outlook Therapeutics (OTLK) EBITDA Margin (2015 - 2025)
Outlook Therapeutics (OTLK) posted quarterly EBITDA Margin of 18863.9% for Q3 2025, up 1903.09% quarter-over-quarter from 1046.2% in Q2 2025.
Outlook Therapeutics (OTLK) EBITDA Margin (2015 - 2025) Analysis & Trends
Outlook Therapeutics (OTLK) has reported EBITDA Margin for 6 consecutive years, with 18863.9% the latest figure, recorded in Q3 2025.
- In Q3 2025, EBITDA Margin changed N/A year-over-year to 18863.9%; the TTM figure through Sep 2025 stood at 854.19% (changed N/A YoY), while the FY2025 annual figure was 4744.25%, changed N/A from the prior year.
- EBITDA Margin grew to 18863.9% in Q3 2025 per OTLK's latest filing, from 1046.2% in the prior quarter.
- Across five years, EBITDA Margin topped out at 18863.9% in Q3 2025 and bottomed at 1046.2% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.41 Bn | 131.56 Bn | 2.84 Bn | 37.40% |
| 2 | Regeneron Pharmaceuticals | 86.14 Bn | 78.15 Bn | 3.93 Bn | 30.15% |
| 3 | Argenx Se | 65.52 Bn | 60.34 Bn | 1.37 Bn | 32.54% |
| 4 | Moderna | 58.21 Bn | 53.07 Bn | 52.00 Mn | -562.07% |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn | 19.06% |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn | 17.93% |
| 7 | BioNTech SE | 27.95 Bn | 9.56 Bn | 668.28 Mn | -35.57% |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.36% |
| 9 | Royalty Pharma | 27.30 Bn | 26.46 Bn | - | 19.75% |
| 10 | Outlook Therapeutics | 90.59 Mn | 79.35 Mn | -8,265.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 18,863.90% |
| Jun 30, 2025 | -1,046.20% |
| Sep 30, 2019 | -216.83% |
| Jun 30, 2019 | -966.72% |
| Mar 31, 2019 | -1,201.86% |
| Dec 31, 2018 | -960.78% |
| Sep 30, 2018 | -1,608.21% |
| Jun 30, 2018 | -935.35% |
| Mar 31, 2018 | -884.97% |
| Dec 31, 2017 | -411.95% |
| Sep 30, 2017 | -100.29% |
| Jun 30, 2017 | -2,420.14% |
| Mar 31, 2017 | -2,585.60% |
| Dec 31, 2016 | -5,870.30% |
| Sep 30, 2016 | -2,011.04% |
| Jun 30, 2016 | -4,450.95% |
| Mar 31, 2016 | -296.91% |
| Dec 31, 2015 | -1,649.75% |
| Sep 30, 2015 | -3,510.23% |
| Jun 30, 2015 | -853.02% |